{"organizations": [], "uuid": "9da577e262e62ee1349c86399de0e51999f27257", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180424.html", "section_title": "Archive News &amp; Video for Tuesday, 24 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/edwards-lifesci-results/edwards-lifesciences-reports-1-3-pct-rise-in-quarterly-sales-idUSL3N1S166J", "country": "US", "domain_rank": 408, "title": "Edwards Lifesciences reports 1.3 pct rise in quarterly sales", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.348, "site_type": "news", "published": "2018-04-25T04:17:00.000+03:00", "replies_count": 0, "uuid": "9da577e262e62ee1349c86399de0e51999f27257"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/edwards-lifesci-results/edwards-lifesciences-reports-1-3-pct-rise-in-quarterly-sales-idUSL3N1S166J", "ord_in_thread": 0, "title": "Edwards Lifesciences reports 1.3 pct rise in quarterly sales", "locations": [], "entities": {"persons": [{"name": "manas mishra", "sentiment": "none"}, {"name": "arun koyyur", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "edwards lifesciences", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "edwards lifesciences corp", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": " Medical device maker Edwards Lifesciences Corp reported a 1.3 percent rise in first-quarter revenue on Tuesday on higher demand for transcatheter heart valves, its biggest business.\nThe companyâ€™s net profit fell to $206.6 million, or 96 cents a share, in the quarter ended March 31, compared with a $230.2 million, or $1.06 per share, a year earlier.\nNet sales in the quarter rose to $894.8 million from $883.5 million a year earlier.\nReporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-25T04:17:00.000+03:00", "crawled": "2018-04-25T14:15:41.030+03:00", "highlightTitle": ""}